| Lantheus Holdings, Inc | $6.6b | $101.79 | +0.2% | 235.2K | |
| AbCellera Biologics Inc. Common Shares | $3.9b | $11.16 | -3.5% | 1.4M | |
| Immunome, Inc. | $2.4b | $17.95 | -4.3% | 390.4K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.3b | $11.98 | -10.4% | 1.6M | |
| Aktis Oncology, Inc. Common stock | $0.8b | $16.48 | -0.8% | 197.2K | |
| Crescent Biopharma, Inc. Common Stock | $485.1m | $13.24 | -4.0% | 115.0K | |
| Perspective Therapeutics, Inc. | $100.5m | $0.93 | -1.8% | 1.5M | |
| Actinium Pharmaceuticals, Inc | $44.0m | $1.52 | -8.5% | 247.4K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.91 | 0.0% | N/A | |
| iTonic Holdings Ltd Class A Ordinary Shares | $16.5m | $1.91 | 0.0% | 20.5K | |
| American Shared Hospital Services | $8.2m | $1.11 | +2.2% | 17.0K |